PATH $12.13 pre-market 24 Mar 2026 (UiPath, NYSE): AI stock outlook

PATH stock opens pre-market at $12.13, after UiPath Inc. reported a March quarter beat. The company posted EPS $0.30 and revenue $481.11M, topping estimates and supporting the stock in early trading. Traders in the United States on the NYSE will watch guidance and monthly adoption of AI-driven RPA. This update ties the quarter’s results to valuation and near-term catalysts for investors tracking AI stocks.

PATH stock snapshot and trading metrics

UiPath Inc. (PATH) trades on the NYSE in USD with a market cap of $6.49B. The stock opened pre-market at $12.13, with a day range of $11.78–$12.26 and 50-day/200-day averages of $12.64 and $13.40 respectively. Volume sits near 17.50M versus an average of 35.00M, showing lighter trading ahead of the next catalyst.

PATH stock earnings and financials

PATH reported EPS $0.30 for the quarter, beating the $0.25 estimate, and revenue of $481.11M versus $464.81M consensus. UiPath’s net margin is 17.53% and trailing EPS is 0.52, supporting a trailing P/E near 23.33. The company maintains $2.75 cash per share and a current ratio of 2.48, which supports near-term liquidity as enterprise customers scale AI automation.

PATH stock analyst view and price targets

Analysts have trimmed targets after recent updates; the consensus price target sits around $14.07. Several firms cut targets to the $12.00–$15.00 range this month. See MarketBeat for analyst coverage and the MarketWatch data download for historical pricing. MarketBeat analyst consensus and targets and MarketWatch PATH historical data.

PATH stock technicals and market context

Technically, PATH shows neutral momentum. RSI is 52.61 and MACD histogram is 0.19, indicating mixed short-term bias. Bollinger upper and lower bands are $12.88 and $10.03, framing a compression ahead of earnings and guidance. The AI software sector is modestly positive, and sector flows will affect PATH trading in the United States.

PATH stock risks and opportunities

Opportunity: UiPath benefits from rising demand for AI-driven RPA across banking and healthcare, supporting recurring revenue growth near 9.30% year-over-year. Risk: Insider selling and mixed analyst cuts increase short-term volatility. Receivables days at 131.60 raise execution risk on collection efficiency as enterprise deals scale.

Meyka Stock Grade and model forecast for PATH stock

Meyka AI rates PATH with a score out of 100: Score 77.35 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 comparison, sector trends, financial growth, key metrics, analyst consensus, and forecasts. Meyka AI’s forecast model projects a 12‑month target of $13.83 USD, implying +14.05% upside from $12.13. These grades and forecasts are model-based projections and not guarantees. For more on our live data, visit Meyka’s PATH page at Meyka PATH page.

Final Thoughts

PATH stock trades at $12.13 pre-market on 24 Mar 2026 after a quarter that beat on EPS and revenue. Fundamentals show improving profitability, with net margin at 17.53% and free cash flow yield near 5.43%, while valuation sits at a trailing P/E of 23.33. Analyst targets cluster near $14.07, and Meyka AI’s forecast model projects $13.83 USD, about 14.05% above the current price. Short-term risks include insider selling and a long receivables cycle, but demand for AI automation in enterprise workflows supports medium-term growth. Use PATH stock exposure as part of an AI-focused allocation, sized to risk tolerance and diversified across software leaders and cyclicals. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.